abstract |
The current disclosure provides methods of treating breast cancer, including triple negative breast cancer. The methods disclosed herein include administering (a) a taxane-containing cationic liposomal formulation, (a) a taxane-containing non-liposomal formulation, and (c) other active agents. The other active agent mentioned above is preferably gemcitabine. |